Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company…
Continue Reading →
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an…
Continue Reading →
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
Continue Reading →
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the…
Continue Reading →
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of…
Continue Reading →
Over the past three years, Genmab has retained The Chase Group to execute four Director, Drug Safety and Pharmacovigilance (PV) physician searches that all concluded…
Continue Reading →
The Chase Group is pleased to announce their continued partnership with Biologics Consulting after being retained to execute a search for a Business Development Lead….
Continue Reading →
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer…
Continue Reading →
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Continue Reading →
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Continue Reading →